Divis Laboratories reports 52% rise in Q3 net profit

04 Feb 2014 Evaluate

Divis Laboratories has reported results for third quarter ended December 31, 2013.

The company has reported 51.84% rise in its net profit at Rs 219.02 crore for the quarter, as compared to Rs 144.24 crore for the same quarter in the previous year. Total income of the company increased by 25.24% at Rs 697.18 crore for quarter under review as compared to Rs 556.68 crore for the quarter ended December 31, 2012.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×